FGFR1 inhibition in lung squamous cell carcinoma: questions and controversies
CE Weeden, B Solomon, M-L Asselin-Labat
Cell Death Discovery | NATURE PUBLISHING GROUP | Published : 2015
M-LA-L is supported by Australian Research Council Queen Elizabeth II Fellowship. CEW is supported by an Australian Postgraduate Award. BS is supported by a Clinical Research Fellowship from the Victorian Cancer Agency. This work was supported in part by an Australian National Health and Medical Research Council grant to M-LA-L. This work was made possible through Victorian State Government Operational Infrastructure Support and Australian Government NHMRC IRIISS.